Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1972-1981

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Johansson, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Johansson, B. B.

(Stroke. 1998;29:1972-1981.)
© 1998 American Heart Association, Inc.


Original Contributions

Neuronal Damage and Plasticity Identified by Microtubule-Associated Protein 2, Growth-Associated Protein 43, and Cyclin D1 Immunoreactivity After Focal Cerebral Ischemia in Rats

Yi Li, MD; Ning Jiang, MD; Cecylia Powers, BS; Michael Chopp, PhD

From the Department of Neurology, Henry Ford Health Sciences Center, Detroit, Mich (Y.L., N.J., C.P., M.C.), and Department of Physics, Oakland University, Rochester, Mich (C.P.).

Correspondence to Michael Chopp, PhD, Henry Ford Hospital, Neurology Department, 2799 W Grand Blvd, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu

Background and Purpose—An objective of therapeutic intervention after cerebral ischemia is to promote improved functional outcome. Improved outcome may be associated with a reduction of the volume of cerebral infarction and the promotion of cerebral plasticity. In the developing brain, neuronal growth is concomitant with expression of particular proteins, including microtubule-associated protein 2 (MAP-2), growth-associated protein 43 (GAP-43), and cyclin D1. In the present study we measured the expression of select proteins associated with neurite damage and plasticity (MAP-2 and GAP-43) as well as cell cycle (cyclin D1) after induction of focal cerebral ischemia in the rat.

Methods—Brains from rats (n=28) subjected to 2 hours of middle cerebral artery occlusion and 6 hours, 12 hours, and 2, 7, 14, 21, and 28 days (n=4 per time point) of reperfusion and control sham-operated (n=3) and normal (n=2) rats were processed by immunohistochemistry with antibodies raised against MAP-2, GAP-43, and cyclin D1. Double staining of these proteins for cellular colocalization was also performed.

Results—Loss of immunoreactivity of both MAP-2 and GAP-43 was observed in most damaged neurons in the ischemic core. In contrast, MAP-2, GAP-43, and cyclin D1 were selectively increased in morphologically intact or altered neurons localized to the ischemic core at an early stage (eg, 6 hours) of reperfusion and in the boundary zone to the ischemic core (penumbra) during longer reperfusion times.

Conclusions—The selective expressions of the neuronal structural proteins (MAP-2 in dendrites and GAP-43 in axons) and the cyclin D1 cell cycle protein in neurons observed in the boundary zone to the ischemic core are suggestive of compensatory and repair mechanisms in ischemia-damaged neurons after transient focal cerebral ischemia.

Editorial Comment

Barbro B. Johansson, MD, PhD, Guest Editor

Laboratory for Experimental Neurology Wallenberg Neuroscience Center Lund University Hospital Lund, Sweden




This article has been cited by other articles:


Home page
J. Neurosci.Home page
I. R. Winship and T. H. Murphy
In Vivo Calcium Imaging Reveals Functional Rewiring of Single Somatosensory Neurons after Stroke
J. Neurosci., June 25, 2008; 28(26): 6592 - 6606.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. T. Carmichael
Themes and Strategies for Studying the Biology of Stroke Recovery in the Poststroke Epoch
Stroke, April 1, 2008; 39(4): 1380 - 1388.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
J. Epsztein, Y. Ben-Ari, A. Represa, and V. Crepel
Late-Onset Epileptogenesis and Seizure Genesis: Lessons From Models of Cerebral Ischemia
Neuroscientist, February 1, 2008; 14(1): 78 - 90.
[Abstract] [PDF]


Home page
Stem CellsHome page
X. Cui, J. Chen, A. Zacharek, Y. Li, C. Roberts, A. Kapke, S. Savant-Bhonsale, and M. Chopp
Nitric Oxide Donor Upregulation of Stromal Cell-Derived Factor-1/Chemokine (CXC Motif) Receptor 4 Enhances Bone Marrow Stromal Cell Migration into Ischemic Brain After Stroke
Stem Cells, November 1, 2007; 25(11): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. D. Schaechter, C. I. Moore, B. D. Connell, B. R. Rosen, and R. M. Dijkhuizen
Structural and functional plasticity in the somatosensory cortex of chronic stroke patients
Brain, October 1, 2006; 129(10): 2722 - 2733.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J Mocco, W. J. Mack, A. F. Ducruet, S. A. Sosunov, M. E. Sughrue, B. G. Hassid, M. N. Nair, I. Laufer, R. J. Komotar, M. Claire, et al.
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
Circ. Res., July 21, 2006; 99(2): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Chen, A. Zacharek, C. Zhang, H. Jiang, Y. Li, C. Roberts, M. Lu, A. Kapke, and M. Chopp
Endothelial Nitric Oxide Synthase Regulates Brain-Derived Neurotrophic Factor Expression and Neurogenesis after Stroke in Mice
J. Neurosci., March 2, 2005; 25(9): 2366 - 2375.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Zepeda, F. Sengpiel, M. A. Guagnelli, L. Vaca, and C. Arias
Functional Reorganization of Visual Cortex Maps after Ischemic Lesions Is Accompanied by Changes in Expression of Cytoskeletal Proteins and NMDA and GABAA Receptor Subunits
J. Neurosci., February 25, 2004; 24(8): 1812 - 1821.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. M. M. Parry, R. B. Scott, J. Palace, S. Smith, and P. M. Matthews
Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine
Brain, December 1, 2003; 126(12): 2750 - 2760.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. T. Carmichael
Plasticity of Cortical Projections after Stroke
Neuroscientist, February 1, 2003; 9(1): 64 - 75.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. Katchanov, C. Harms, K. Gertz, L. Hauck, C. Waeber, L. Hirt, J. Priller, R. von Harsdorf, W. Bruck, H. Hortnagl, et al.
Mild Cerebral Ischemia Induces Loss of Cyclin-Dependent Kinase Inhibitors and Activation of Cell Cycle Machinery before Delayed Neuronal Cell Death
J. Neurosci., July 15, 2001; 21(14): 5045 - 5053.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. C. Cramer, G. Nelles, J. D. Schaechter, J. D. Kaplan, S. P. Finklestein, and B. R. Rosen
A Functional MRI Study of Three Motor Tasks in the Evaluation of Stroke Recovery
Neurorehabil Neural Repair, January 1, 2001; 15(1): 1 - 8.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Osuga, S. Osuga, F. Wang, R. Fetni, M. J. Hogan, R. S. Slack, A. M. Hakim, J.-E Ikeda, and D. S. Park
Cyclin-dependent kinases as a therapeutic target for stroke
PNAS, August 10, 2000; (2000) 170144197.
[Abstract] [Full Text]


Home page
StrokeHome page
B. B. Johansson
Brain Plasticity and Stroke Rehabilitation : The Willis Lecture
Stroke, January 1, 2000; 31(1): 223 - 230.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Osuga, S. Osuga, F. Wang, R. Fetni, M. J. Hogan, R. S. Slack, A. M. Hakim, J.-E Ikeda, and D. S. Park
Cyclin-dependent kinases as a therapeutic target for stroke
PNAS, August 29, 2000; 97(18): 10254 - 10259.
[Abstract] [Full Text] [PDF]